MTX-439

N/A

Report date: 2026/05/21 20:00:22

Base Information

Drug NameMTX-439
Drug Alias NameMTX-439MTX439
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionSPARC-related modular calcium-binding protein 2 antagonists
TargetsSPARC-related modular calcium-binding protein 2
Therapy Area/IndicationsRenal fibrosisDiabetic Nephropathies
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesAustralia
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesMediar Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesMediar Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsRenal fibrosisDiabetic Nephropathies
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A